Five drug groups want to have their products included in the new three-year pilot scheme for risk sharing in which companies cover additional reimbursement expenses if their products are prescribed for patients outside the defined target group. However, the pilot scheme will only covertwo medicines.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.